08.04.2014 • NewsBayerDede WillamsGE

Momentive Performance Materials May File for Chapter 11

Silicone and quartz producer Momentive Performance Materials (MPM) is said to be close to filing for U.S. Chapter 11 bankruptcy protection as the company belonging to private equity group Apollo strives to reduce its debt burden of around $3 billion and kick-start restructuring.

Put together from assets formerly owned by GE, Bayer and Toshiba, MPM has found it hard to repay what it says is "a substantial amount of institutional debt," due to continued weakness in demand and overcapacity in its industry.

Apollo acquired the holding for MPM and sister firm Momentive Specialty Chemicals, formerly trading as Hexion Specialty Chemicals, for $3.8 billion in 2006 and is said to have saddled the first company with additional debt ahead of a recession that fueled oversupply in the silicone market.

Any bankruptcy filing would exclude the specialty chemicals producer, described as having a "solid" financial position.

MPM expects figures for 2013 to show a net loss of around $465 million after a $365 million net loss in 2012, driven primarily by non-cash adjustments related to concerns about its ability to continue as a going concern.

News agencies have reported that a group of  secured debt holders holding a substantial portion of MPM's $1.1-billion, 8.875% first lien notes due in 2020 have selected New York law firm Dechert as counsel in connection with any potential restructuring of the company.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.